TGF-β1 signaling is essential for the progression of renal fibrosis and has been proposed as a therapeutic target for CKD (Figure 2), however systematically targeting TGF-β1 would also suppress its physiological functions and may result in adverse side effects (167, 168). Here, TGFB1 is linked to renal fibrosis.